-+ 0.00%
-+ 0.00%
-+ 0.00%

Maze Therapeutics prices $150 million follow-on stock offering at $23.5 per share

PUBT·04/22/2026 04:09:59
Listen to the news
Maze Therapeutics prices $150 million follow-on stock offering at $23.5 per share
  • Maze Therapeutics priced an underwritten registered offering of 5,540,000 common shares at USD 23.5 per share.
  • Offering also includes pre-funded warrants for up to 850,000 shares at USD 23.499 per warrant.
  • Gross proceeds expected at about USD 150 million.
  • Leerink Partners acting as sole underwriter.
  • Net proceeds earmarked for R&D programs including MZE829 and MZE782, with cash runway projected into 2029.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604220009PRIMZONEFULLFEED9694725) on April 22, 2026, and is solely responsible for the information contained therein.